Glaxo asthma drug Advair’s patent invalid, rules German court

Glaxo asthma drug Advair’s patent invalid, rules German court
A key patent on GlaxoSmithKline’s top-selling asthma drug, Advair, has been deemed invalid by a German court, potentially paving the way for generic competition.